CR rates in relapsed/refractory (R/R) aggressive B-NHL treated with the CD19-directed CAR T-cell product JCAR017 (TRANSCEND NHL 001) Meeting Abstract
| Authors: | Abramson, J. S.; Palomba, M. L.; Gordon, L. I.; Lunning, M. A.; Arnason, J. E.; Forero-Torres, A.; Wang, M.; Albertson, T. M.; Allen, T.; Sutherland, C.; Xie, B.; Garcia, J.; Siddiqi, T. |
| Abstract Title: | CR rates in relapsed/refractory (R/R) aggressive B-NHL treated with the CD19-directed CAR T-cell product JCAR017 (TRANSCEND NHL 001) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 395s |
| Language: | English |
| ACCESSION: | WOS:000411931708182 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.7513 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 7513 -- Source: Wos |
